Serological response to COVID-19 and association with MR containing vaccine
Not Applicable
Completed
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2021/01/030363
- Lead Sponsor
- niversity College of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 90
Inclusion Criteria
Group 1: COVID-19 positive children who have received MR-containing vaccine atleast 6 weeks before date of enrolment
Group 2: COVID 19 positive children who have not received MR containing vaccine
Exclusion Criteria
Children with past infection due to measles or rubella, immunodeficiency states (both primary and secondary), chronic diseases (congenital heart disease, respiratory diseases that cause pulmonary function impairment, hypothyroidism, IDDM), history of blood transfusion within last 3 months, severe malnutrition (wt-for-ht <-3SD, MUAC <11.5cm, or bilateral pedal edema of nutritional origin), malignancy
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method